Ironwood Pharmaceuticals (IRWD) Depreciation & Amortization (CF) (2016 - 2026)
Ironwood Pharmaceuticals' Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $460000.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 5.15% to $460000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 6.46% decrease, with the full-year FY2025 number at $1.1 million, down 8.33% from a year prior.
- Depreciation & Amortization (CF) hit $460000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $475000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for IRWD hit a ceiling of $513000.0 in Q1 2024 and a floor of $270000.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $420400.0 across 5 years, with a median of $435000.0 in 2021.
- Biggest five-year swings in Depreciation & Amortization (CF): tumbled 80.34% in 2021 and later surged 87.41% in 2024.
- Tracing IRWD's Depreciation & Amortization (CF) over 5 years: stood at $359000.0 in 2021, then decreased by 5.29% to $340000.0 in 2022, then skyrocketed by 50.59% to $512000.0 in 2023, then dropped by 5.27% to $485000.0 in 2024, then fell by 5.15% to $460000.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for IRWD at $460000.0 in Q4 2025, $475000.0 in Q3 2025, and $467000.0 in Q2 2025.